X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (144) 144
Publication (40) 40
Paper (35) 35
Book / eBook (5) 5
Book Review (4) 4
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (68) 68
humans (44) 44
nuclear experiment (38) 38
experiment (35) 35
physics (34) 34
nuclear physics (32) 32
particle physics (30) 30
hiv antibodies - immunology (29) 29
animals (28) 28
hep (28) 28
high energy physics - experiment (28) 28
nucl (28) 28
antibodies, neutralizing - immunology (25) 25
article (21) 21
hiv-1 - immunology (21) 21
antibodies (20) 20
hiv (19) 19
research (18) 18
high energy physics (16) 16
hiv infections - immunology (16) 16
human immunodeficiency virus--hiv (16) 16
multidisciplinary sciences (16) 16
binding sites (15) 15
ex (15) 15
immunology (15) 15
mutation (15) 15
models, biological (14) 14
respiration (13) 13
space life sciences (13) 13
b-lymphocytes - immunology (12) 12
hiv envelope protein gp120 - chemistry (12) 12
hiv envelope protein gp120 - immunology (12) 12
epitopes - immunology (11) 11
human monoclonal-antibodies (11) 11
molecular sequence data (11) 11
rational design (11) 11
virus diseases (11) 11
amino acid sequence (10) 10
human-immunodeficiency-virus (10) 10
immunoglobulins (10) 10
male (10) 10
monoclonal-antibodies (10) 10
oxygen - blood (10) 10
vaccines (10) 10
viral antibodies (10) 10
virology (10) 10
viruses (10) 10
antibodies, neutralizing - chemistry (9) 9
broadly neutralizing antibodies (9) 9
crystallography, x-ray (9) 9
env gene products, human immunodeficiency virus - immunology (9) 9
female (9) 9
health aspects (9) 9
hep-ex (9) 9
hiv antibodies (9) 9
hiv antibodies - chemistry (9) 9
hiv antibodies - genetics (9) 9
nuclear physics - experiment (9) 9
particle physics - experiment (9) 9
physics of elementary particles and fields (9) 9
carbon dioxide - blood (8) 8
cd4 antigens - metabolism (8) 8
cd4 binding (8) 8
hiv infection (8) 8
hiv-1 - genetics (8) 8
neutralization tests (8) 8
nucl-ex (8) 8
antibodies, monoclonal - immunology (7) 7
diffusion (7) 7
dogs (7) 7
envelope glycoprotein (7) 7
epitope (7) 7
hek293 cells (7) 7
hiv envelope protein gp120 - metabolism (7) 7
immunodeficiency-virus type-1 (7) 7
individuals (7) 7
middle aged (7) 7
models, molecular (7) 7
neutralizing antibodies (7) 7
partial pressure (7) 7
passive transfer (7) 7
physiological aspects (7) 7
physiology (7) 7
protein binding (7) 7
adult (6) 6
aids vaccines - immunology (6) 6
antigens (6) 6
b-cells (6) 6
biology (6) 6
cd4 antigens - immunology (6) 6
cloning (6) 6
hiv-1 (6) 6
infection (6) 6
infections (6) 6
microbiology (6) 6
physics, particles & fields (6) 6
protection (6) 6
proteins (6) 6
respiratory system (6) 6
vaccine (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2012, Volume 109, Issue 47, pp. E3268 - E3277
Journal Article
Science, ISSN 0036-8075, 8/2010, Volume 329, Issue 5993, pp. 811 - 817
Journal Article
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system | Index Medicus
Journal Article
Science, ISSN 0036-8075, 9/2011, Volume 333, Issue 6049, pp. 1633 - 1637
Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elicit such antibodies would be protective.... 
Germ cells | HIV | B lymphocytes | Neutralizing antibodies | REPORTS | Antibodies | Bone marrow | Plasma cells | Viruses | Trimers | Inhibitory concentration 50 | INDIVIDUALS | MEMORY B-CELLS | NEUTRALIZING ANTIBODIES | EPITOPE | TYPE-1 GP120 | MULTIDISCIPLINARY SCIENCES | GP41 | ENVELOPE GLYCOPROTEIN | RECEPTOR | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | Consensus Sequence | Antibody Specificity | Humans | Antibodies, Neutralizing - metabolism | Immunoglobulin Heavy Chains - chemistry | Molecular Sequence Data | Crystallography, X-Ray | HIV Envelope Protein gp120 - metabolism | Genes, Immunoglobulin Heavy Chain | HIV Envelope Protein gp120 - immunology | Immunoglobulin Light Chains - chemistry | HIV Infections - immunology | Antibodies, Neutralizing - immunology | Molecular Mimicry | HIV Antibodies - immunology | Cloning, Molecular | HIV Envelope Protein gp120 - chemistry | Binding Sites | HIV Antibodies - metabolism | Amino Acid Sequence | CD4 Antigens - immunology | Antibody Affinity | HIV Antibodies - chemistry | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Protein Conformation | Mutation | Binding Sites, Antibody | CD4 Antigens - metabolism | HIV antibodies | Physiological aspects | Genetic aspects | Research | Nucleotide sequencing | Health aspects | Protein binding | Proteins | Immunoglobulins | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Polyclonal antibodies | Index Medicus
Journal Article
Immunity, ISSN 1074-7613, 08/2013, Volume 39, Issue 2, pp. 245 - 258
Journal Article
Nature, ISSN 0028-0836, 07/2016, Volume 535, Issue 7613, pp. 556 - 560
Interruption of combination antiretroviral therapy in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open... 
POTENT | REPLICATION | GENETIC-DETERMINANTS | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | SEQUENCE | CD4 BINDING | ANTIRETROVIRAL THERAPY | INFECTION | MONOCLONAL-ANTIBODIES | Anti-HIV Agents - pharmacology | Antibodies, Neutralizing - administration & dosage | Disease Reservoirs - virology | Humans | Middle Aged | Male | Proviruses - immunology | Anti-HIV Agents - administration & dosage | Tissue Distribution | Young Adult | HIV Infections - immunology | Proviruses - drug effects | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Time Factors | Antibodies, Neutralizing - therapeutic use | Binding Sites - immunology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Binding Sites - drug effects | HIV Envelope Protein gp160 - metabolism | Drug Administration Schedule | HIV-1 - drug effects | HIV Infections - virology | HIV Antibodies - administration & dosage | Viral Load - immunology | Proviruses - growth & development | HIV-1 - immunology | HIV Envelope Protein gp160 - antagonists & inhibitors | Adolescent | HIV Infections - drug therapy | Aged | HIV Envelope Protein gp160 - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Prevention | Antiviral agents | HIV antibodies | Dosage and administration | Host-virus relationships | Drug therapy, Combination | Drug therapy | Health aspects | HIV infection | Methods | Clinical trials | Antiretroviral drugs | Immunoglobulins | Human immunodeficiency virus--HIV | Binding sites | Index Medicus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 01/2013, Volume 9, Issue 1, pp. e1003106 - e1003106
Journal Article
Journal Article